Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients-Reference-Cited by-同舟云学术

Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients

Published:2006-01 Issue:1 Volume:184 Page:72-77
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Asztalos Bela F.,Schaefer Ernst J.,Horvath Katalin V.,Cox Caitlin E.,Skinner Sally,Gerrior Jul,Gorbach Sherwood L.,Wanke Christine

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors;Periard;Circulation,1999

2. Hyperinsulinemia and insulin resistance induced by protease inhibitors independent of changes in body composition in patients with HIV infection;Mulligan;J Aids,2000

3. Hyperlipidemia associated with protease inhibitor therapy;Echevarria;Ann Pharmacother,1999

4. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects;Purnell;Aids,2000

5. Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers;Sadler;Aids,2001

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study;BMC Endocrine Disorders;2023-07-28

2. Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy;The Journal of Infection in Developing Countries;2022-03-31

3. Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study;PLOS ONE;2021-11-29

4. Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings;PLOS ONE;2021-02-16

5. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization;Vascular Medicine;2020-10-06